Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03004326 · ClinicalTrials.gov registry record

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

A clinical trial of Vasculitis and IgA Vasculitis, sponsored by Peter Merkel.

Recruiting
Registry status
50
Enrollment target
10
Study locations

NCT03004326 is a study of Vasculitis and IgA Vasculitis that is actively recruiting participants, run by Peter Merkel. The registered enrollment target is 50 participants, below the 27,314-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03004326, a study of Vasculitis and IgA Vasculitis, is actively recruiting participants, sponsored by Peter Merkel.

RECRUITING
Registry status
50 participants
Enrollment target
10
Study locations

Study Summary

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

Study Locations (10)

Ontario

  • St. Joseph's Healthcare - Hamilton
  • University of Toronto Mount Sinai Hospital - Toronto

California

  • University of California, Los Angeles - Los Angeles

Massachusetts

  • Boston University School of Medicine - Boston

Minnesota

  • Mayo Clinic - Rochester

Ohio

  • Cleveland Clinic - Cleveland

Oregon

  • Oregon Health & Science University - Portland

Pennsylvania

  • University of Pennsylvania - Philadelphia

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-01
Est. Completion 2028-12

Sponsor

Peter Merkel

2 total trials

What the Registry Record Tells You About NCT03004326

The ClinicalTrials.gov registry entry for NCT03004326 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 27,314-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The listed sponsor is Peter Merkel, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.

NCT03004326 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Ontario, California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03004326 about?

NCT03004326 is a clinical study titled "Clinical Transcriptomics in Systemic Vasculitis (CUTIS)". Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

What is the current status of trial NCT03004326?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-01. Estimated completion is 2028-12.

What conditions does trial NCT03004326 study?

This clinical trial studies the following conditions: Vasculitis, IgA Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA).

Who is sponsoring clinical trial NCT03004326?

This trial is sponsored by Peter Merkel, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03004326 being conducted?

This trial has 10 study locations across California, Massachusetts, Minnesota, Ohio, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vasculitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.